COVID-19 Vaccine Trial Begins, and Inovio Pharmaceuticals Price Target Jumps to $17

“Coronavirus.” For most of this year, most people have been just focused on the one — the novel coronavirus dubbed SARS-CoV-19 that has infected the world with a global pandemic of COVID-19. But did you know there are more than just one kind of coronavirus? Did you know the word itself is more of an adjective than a noun?It’s true. “Coronavirus” in fact describes a whole family of viruses typified by their spiky structure that resembles (to some eyes) a “crown,” or “corona” — and as luck would have it, Inovio Pharmaceuticals (INO) may be developing a knack for treating …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.